ProCE Banner Activity

Applying HER2 Testing Results to Treatment Decisions for Patients With Solid Tumors

Slideset

Download this slideset for expert perspectives and key data on HER2-targeted therapy for specific patients with advanced gastroesophageal, colorectal, biliary tract, and lung cancers, as well as a discussion of emerging strategies for HER-altered solid tumors.

Released: March 25, 2025

Expiration: March 24, 2026

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., and Jazz Pharmaceuticals.

AstraZeneca

Daiichi Sankyo, Inc.

Jazz Pharmaceuticals